Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 6, Pages 1609
Publisher
MDPI AG
Online
2020-06-18
DOI
10.3390/cancers12061609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer
- (2020) Sufang Tian et al. Journal of Thoracic Oncology
- Risk of COVID-19 for cancer patients
- (2020) Yang Xia et al. LANCET ONCOLOGY
- The entry of nanoparticles into solid tumours
- (2020) Shrey Sindhwani et al. NATURE MATERIALS
- Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
- (2020) Aaron C. Tan Thoracic Cancer
- Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10
- (2020) William H. Gmeiner et al. Cancers
- In Vitro Anticancer Activity of Extracellular Vesicles (EVs) Secreted by Gingival Mesenchymal Stromal Cells Primed with Paclitaxel
- (2019) Valentina Coccè et al. Pharmaceutics
- Recent clinical trials of immunotherapy in non-small-cell lung cancer
- (2019) Stavros Gkolfinopoulos et al. Immunotherapy
- Silencing AXL by covalent siRNA-gelatin-antibody nanoconjugate inactivates mTOR/EMT pathway and stimulates p53 for TKI sensitization in NSCLC
- (2019) Dhananjay Suresh et al. Nanomedicine-Nanotechnology Biology and Medicine
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- Translatable gene therapy for lung cancer using Crispr CAS9—an exploratory review
- (2019) Jishnu Nair et al. CANCER GENE THERAPY
- Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
- (2019) Xiaohan Zhou et al. Asian Journal of Pharmaceutical Sciences
- Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
- (2019) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
- (2019) Ardeshir R. Rastinehad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extracellular vesicles in cancer nanomedicine
- (2019) Vadim V. Tarasov et al. SEMINARS IN CANCER BIOLOGY
- Applications of CRISPR/Cas9 Technology in the Treatment of Lung Cancer
- (2019) Chunyang Jiang et al. TRENDS IN MOLECULAR MEDICINE
- Targeted Therapy For RET-Rearranged Non-Small Cell Lung Cancer: Clinical Development And Future Directions
- (2019) Christoph Jakob Ackermann et al. OncoTargets and Therapy
- Photothermal-Activatable Fe3O4 Superparticle Nanodrug Carriers with PD-L1 Immune Checkpoint Blockade for Anti-metastatic Cancer Immunotherapy
- (2018) Rui Ge et al. ACS Applied Materials & Interfaces
- Features of COPD as Predictors of Lung Cancer
- (2018) Laurie L. Carr et al. CHEST
- KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
- (2018) Marta Román et al. Molecular Cancer
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- mRNA Delivery System for Targeting Antigen-Presenting Cells In Vivo
- (2018) Cristina Fornaguera et al. Advanced Healthcare Materials
- Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
- (2018) Hye Jung Park et al. Journal of Thoracic Disease
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- DNA-based nanoscaffolds as vehicles for 5-fluoro-2′-deoxyuridine oligomers in colorectal cancer therapy
- (2018) A. F. Jorge et al. Nanoscale
- Bioreducible Poly(Amino Ethers) Based mTOR siRNA Delivery for Lung Cancer
- (2018) Nishant S. Gandhi et al. PHARMACEUTICAL RESEARCH
- Adenosquamous carcinoma of the lung
- (2018) Chenghui Li et al. OncoTargets and Therapy
- Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment
- (2018) Marco Cordani et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The application of nanotechnology in immune checkpoint blockade for cancer treatment
- (2018) Huan Deng et al. JOURNAL OF CONTROLLED RELEASE
- Nanotechnology-based photoimmunological therapies for cancer
- (2018) Yong Li et al. CANCER LETTERS
- An update on the developing mitotic inhibitors for the treatment of non-small cell carcinoma
- (2017) Paola Claudia Sacco et al. EXPERT OPINION ON EMERGING DRUGS
- Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
- (2017) Guangbo Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gold nanoparticles enhance TRAIL sensitivity through Drp1-mediated apoptotic and autophagic mitochondrial fission in NSCLC cells
- (2017) Sunkui Ke et al. International Journal of Nanomedicine
- A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors
- (2017) Hirofumi Mukai et al. INVESTIGATIONAL NEW DRUGS
- Immunotherapy: Cancer vaccines on the move
- (2017) Jacques Banchereau et al. Nature Reviews Clinical Oncology
- Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
- (2017) Barbara Melosky Frontiers in Oncology
- Messenger RNA vaccination in NSCLC: Findings from a phase I/IIa clinical trial.
- (2017) M. Sebastian et al. JOURNAL OF CLINICAL ONCOLOGY
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Phase Ib/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine (G) in patients (pts) with advanced solid tumors
- (2016) V. Subbiah et al. EUROPEAN JOURNAL OF CANCER
- Management of stage I and II nonsmall cell lung cancer
- (2016) Fiona McDonald et al. EUROPEAN RESPIRATORY JOURNAL
- The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence
- (2016) William H Gmeiner et al. Future Oncology
- Materials for non-viral intracellular delivery of messenger RNA therapeutics
- (2016) Kevin J. Kauffman et al. JOURNAL OF CONTROLLED RELEASE
- New and emerging targeted treatments in advanced non-small-cell lung cancer
- (2016) Fred R Hirsch et al. LANCET
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Immune Checkpoint Inhibitors in Non‐Small Cell Lung Cancer
- (2016) Benjamin Herzberg et al. ONCOLOGIST
- FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1
- (2016) Joohee Sul et al. ONCOLOGIST
- FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy
- (2016) Dickran Kazandjian et al. ONCOLOGIST
- Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells
- (2016) Akhil Srivastava et al. Scientific Reports
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Multimodality imaging in nanomedicine and nanotheranostics
- (2016) Xue Li et al. Cancer Biology & Medicine
- Surface charge tunability as a powerful strategy to control electrostatic interaction for high efficiency silencing, using tailored oligopeptide-modified poly(beta-amino ester)s (PBAEs)
- (2015) Pere Dosta et al. Acta Biomaterialia
- Emerging Immunotherapies in the Treatment of Non–small Cell Lung Cancer (NSCLC)
- (2015) Corey J. Langer AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells
- (2015) Heikki Saari et al. JOURNAL OF CONTROLLED RELEASE
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Biomaterials for mRNA delivery
- (2015) Mohammad Ariful Islam et al. Biomaterials Science
- Non-small-cell lung cancer
- (2015) Cesare Gridelli et al. Nature Reviews Disease Primers
- Oligopeptide-terminated poly(β-amino ester)s for highly efficient gene delivery and intracellular localization
- (2014) Nathaly Segovia et al. Acta Biomaterialia
- Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
- (2014) Claudia Fumarola et al. BIOCHEMICAL PHARMACOLOGY
- Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
- (2014) Martin Sebastian et al. BMC CANCER
- A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
- (2014) Hee Kyung Ahn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Vaccination therapy for non-small-cell lung cancer
- (2014) Kristof Cuppens et al. CURRENT OPINION IN ONCOLOGY
- Lipid-based mRNA vaccine delivery systems
- (2014) Patrick Midoux et al. Expert Review of Vaccines
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016)
- (2014) Takasyoshi Ueno et al. International Journal of Nanomedicine
- New modalities of cancer treatment for NSCLC: focus on immunotherapy
- (2014) Marianne Davies Cancer Management and Research
- Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression
- (2013) Kai-hua Lu et al. BMC CANCER
- Methods for Staging Non-small Cell Lung Cancer
- (2013) Gerard A. Silvestri et al. CHEST
- Adjuvant MAGE-A3 Immunotherapy in Resected Non–Small-Cell Lung Cancer: Phase II Randomized Study Results
- (2013) Johan Vansteenkiste et al. JOURNAL OF CLINICAL ONCOLOGY
- Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC
- (2013) Yuan Zhang et al. MOLECULAR THERAPY
- Surgery for NSCLC in the era of personalized medicine
- (2013) Tetsuya Mitsudomi et al. Nature Reviews Clinical Oncology
- Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
- (2013) Shanthi Ganesh et al. Molecular Therapy-Nucleic Acids
- Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) S. Peters et al. ANNALS OF ONCOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiotherapy for NSCLC: Review of conventional and new treatment techniques
- (2012) Ahmed Saadeddin Journal of Infection and Public Health
- EGFR Mutations and Lung Cancer
- (2011) Gilda da Cunha Santos et al. Annual Review of Pathology-Mechanisms of Disease
- Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
- (2011) Elisabeth Quoix et al. LANCET ONCOLOGY
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- Ipilimumab: its potential in non-small cell lung cancer
- (2011) Pascale Tomasini et al. Therapeutic Advances in Medical Oncology
- MAGE A3 antigen-specific cancer immunotherapeutic
- (2010) Nir Peled et al. Immunotherapy
- Pilot Study of 1650-G: A Simplified Cellular Vaccine for Lung Cancer
- (2010) Edward A. Hirschowitz et al. Journal of Thoracic Oncology
- Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
- (2010) Alex Chang LUNG CANCER
- Cell of origin of lung cancer
- (2010) Kate D. Sutherland et al. Molecular Oncology
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Staging of non-small cell lung cancer (NSCLC): A review
- (2010) S. Tsim et al. RESPIRATORY MEDICINE
- S-1: A New Oral Fluoropyrimidine in the Treatment of Patients with Advanced Non–Small-Cell Lung Cancer
- (2009) Isamu Okamoto et al. Clinical Lung Cancer
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started